Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2
BioFactors · 2025
DOI: 10.1002/biof.2154 ↗At a glance
Journal article in BioFactors, 2025. Written by Yosuke Shikama and 5 co-authors. Institution: Department of Oral Disease Research, National Center for Geriatrics and Gerontology, Obu, Japan. Major MEDLINE topics: Angiotensin-Converting Enzyme 2, Metformin, Serine Endopeptidases, Salivary Glands. Cited 2 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Society for the Promotion of Science, Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology.
Abstract (original language)
SARS‐CoV‐2‐related proteins, ACE2 and TMPRSS2, are determinants of SARS‐CoV‐2 infection. Although these proteins are expressed in oral‐related tissues, their expression patterns and modulatory mechanisms in the salivary glands remain unknown. We herein showed that full‐length ACE2, which has both a fully functional enzyme catalytic site and high‐affinity SARS‐CoV‐2 spike S1‐binding sites, was more highly expressed in salivary glands than in oral mucosal epithelial cells and the lungs. Regarding TMPRSS2, zymogen and the cleaved form were both expressed in the salivary glands, whereas only zymogen was expressed in murine lacrimal glands and the lungs. Metformin, an AMPK activator, increased stimulated saliva secretion and full‐length ACE2 expression and decreased cleaved TMPRSS2 expression in the salivary glands, and exerted the same effects on soluble ACE2 (sACE2) and sTMPRSS2 in saliva. Moreover, metformin decreased the expression of beta‐galactosidase, a senescence marker, and ADAM17, a sheddase of ACE2 to sACE2, in the salivary glands. In aged mice, the expression of ACE2 was decreased in the salivary glands, whereas that of sACE2 was increased in saliva, presumably by the up‐regulated expression of ADAM17. The expression of TMPRSS2 in the salivary glands and sTMPRSS2 in saliva were both increased. Collectively, these results suggest that the protein expression patterns of ACE2 and TMPRSS2 in the salivary glands differ from those in other oral‐related cells and tissues, and also that metformin and aging affect the salivary expression of ACE2 and TMPRSS2, which have the potential as targets for preventing the transmission of SARS‐CoV‐2.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Oral Disease Research, National Center for Geriatrics and Gerontology, Obu, Japan.
- Department of Geriatric Oral Science, Graduate School of Dentistry, Tohoku University, Sendai, Japan.
- Department of Oral Molecular Pathology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
- Department of Oral Pathology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
ORCID profiles: Yosuke Shikama, Kunihiro Otsuka
Funding
- Japan Society for the Promotion of Science
- Research Funding for Longevity Sciences from the National Center for Geriatrics and Gerontology
Cite
APA
Shikama, Y., Otsuka, K., Shikama, Y., Furukawa, M., Ishimaru, N., & Matsushita, K. (2025). Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2. BioFactors. https://doi.org/10.1002/biof.2154
Vancouver
Shikama Y, Otsuka K, Shikama Y, Furukawa M, Ishimaru N, Matsushita K. Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2. BioFactors. 2025. doi:10.1002/biof.2154
BibTeX
@article{Shikama2025,
author = {Shikama, Yosuke and Otsuka, Kunihiro and Shikama, Yuka and Furukawa, Masae and Ishimaru, Naozumi and Matsushita, Kenji},
title = {Involvement of metformin and aging in salivary expression of ACE2 and TMPRSS2},
journal = {BioFactors},
year = {2025},
doi = {10.1002/biof.2154}
}
EUVIMED